Literature DB >> 14698531

Women's susceptibility to tobacco carcinogens.

Claudia I Henschke1, Olli S Miettinen.   

Abstract

STUDY
OBJECTIVES: To assess lung cancer risk of smoking women relative to that of equally smoking men.
METHODS: The study base was constituted by baseline CT screenings for lung cancer on 1202 women and 1288 men, at least 40 years of age and with at least 10 pack-years of cigarette smoking. The prevalence-odds (incidence-density) ratio contrasting women with men was calculated. Confoundings by age and the particulars of smoking history were controlled in logistic regression analysis.
RESULTS: For the prevalence-odds ratio contrasting women with men, upon control of age and smoking history, the point estimate was 2.7 and the 95% interval estimate 1.6-4.7. The diagnosed cancers were of equally 'aggressive' types between the two genders.
CONCLUSIONS: At variance with evidence from cohort studies, this evidence from a screening experience calls for further consideration of the hypothesis that women are more susceptible to tobacco carcinogens than are men.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14698531     DOI: 10.1016/j.lungcan.2003.08.024

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  22 in total

1.  Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer.

Authors:  Vei Mah; Diana Marquez; Mohammad Alavi; Erin L Maresh; Li Zhang; Nam Yoon; Steve Horvath; Lora Bagryanova; Michael C Fishbein; David Chia; Richard Pietras; Lee Goodglick
Journal:  Lung Cancer       Date:  2011-04-20       Impact factor: 5.705

2.  The consequences of the unregulated cigarette.

Authors:  Nigel Gray
Journal:  Tob Control       Date:  2006-10       Impact factor: 7.552

Review 3.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 4.  Pharmacotherapy for smoking cessation: current advances and research topics.

Authors:  Tobias Raupach; Constant P van Schayck
Journal:  CNS Drugs       Date:  2011-05       Impact factor: 5.749

5.  An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies.

Authors:  Jay H Lubin; Joshua Muscat; Mia M Gaudet; Andrew F Olshan; Maria Paula Curado; Luigino Dal Maso; Victor Wünsch-Filho; Erich M Sturgis; Neonilia Szeszenia-Dabrowska; Xavier Castellsague; Zuo-Feng Zhang; Elaine Smith; Leticia Fernandez; Elena Matos; Silvia Franceschi; Eleonora Fabianova; Peter Rudnai; Mark P Purdue; Dana Mates; Qingyi Wei; Rolando Herrero; Karl Kelsey; Hal Morgenstern; Oxana Shangina; Sergio Koifman; Jolanta Lissowska; Fabio Levi; Alexander W Daudt; Jose Eluf Neto; Chu Chen; Philip Lazarus; Deborah M Winn; Stephen M Schwartz; Paolo Boffetta; Paul Brennan; Ana Menezes; Carlo La Vecchia; Michael McClean; Renato Talamini; Thangarajan Rajkumar; Richard B Hayes; Mia Hashibe
Journal:  Cancer Causes Control       Date:  2011-07-09       Impact factor: 2.506

6.  Explorations of lung cancer stigma for female long-term survivors.

Authors:  Cati Brown; Janine Cataldo
Journal:  Nurs Inq       Date:  2013-02-16       Impact factor: 2.393

7.  Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy.

Authors:  Suchita Pakkala; Zhengjia Chen; David Rimland; Taofeek K Owonikoko; Clifford Gunthel; Johann R Brandes; Nabil R Saba; Dong M Shin; Walter J Curran; Fadlo R Khuri; Suresh S Ramalingam
Journal:  Cancer       Date:  2011-06-28       Impact factor: 6.860

8.  Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.

Authors:  Anne M Traynor; Joan H Schiller; Laura P Stabile; Jill M Kolesar; Jens C Eickhoff; Sanja Dacic; Tien Hoang; Sarita Dubey; Sarah M Marcotte; Jill M Siegfried
Journal:  Lung Cancer       Date:  2008-08-12       Impact factor: 5.705

9.  Second primary lung cancers: smokers versus nonsmokers after resection of stage I lung adenocarcinoma.

Authors:  R Taylor Ripley; Robert R McMillan; Camelia S Sima; Saad M Hasan; Usman Ahmad; Feiran Lou; David R Jones; Valerie W Rusch; Nabil P Rizk; James Huang
Journal:  Ann Thorac Surg       Date:  2014-07-16       Impact factor: 4.330

10.  Hormone replacement therapy and outcomes for women with non-small-cell lung cancer: can an association be confirmed?

Authors:  O Ayeni; A Robinson
Journal:  Curr Oncol       Date:  2009-05       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.